series-c-plus
Stage
2010
Founded
1
Investors
About
BeiGene is a global biotechnology company that is developing and commercializing innovative oncology medicines to improve treatment outcomes and access for patients worldwide.
Explore BeiGene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.